Patents by Inventor Yathi M. Naidu

Yathi M. Naidu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotides and methods for inhibiting cellular proliferation
    Patent number: 5945336
    Abstract: The present invention relates to methods of treating disease-associated cellular proliferation using oligonucleotides. In particular, it relates to the use of oligonulceotides which are substantially complementary to interleukin-6 receptor mRNA sequences. In the form of pharmaceutical compositions, these oligonucleotides are suitable for administration to human subjects for the treatment of abnormal cellular proliferation due to such diseases as cancer, autoimmune disorders and viral infection.
    Type: Grant
    Filed: November 21, 1997
    Date of Patent: August 31, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Steven Joel Brown, Nanibhushan Dattagupta, Yathi M. Naidu
  • Oligonucleotides specific for cytokine signal transducer gp130 mRNA
    Patent number: 5780612
    Abstract: The present invention relates to oligonucleotides which are effective inhibitors of disease-associated cellular proliferation. In particular, it relates to the use of oligonulceotides which are substantially complementary to gp130 mRNA sequences. In the form of pharmaceutical compositions, these oligonucleotides are suitable for administration to human subjects for the treatment of abnormal cellular proliferation due to such diseases as cancer, autoimmune disorders and viral infection.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: July 14, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Kathleen Ann Becherer, Nanibhushan Dattagupta, Yathi M. Naidu
  • Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
    Patent number: 5747470
    Abstract: The present invention relates to methods of treating disease-associated cellular proliferation using oligonucleotides. In particular, it relates to the use of oligonulceotides which are substantially complementary to gp13O mRNA sequences. In the form of pharmaceutical compositions, these oligonucleotides are suitable for administration to human subjects for the treatment of abnormal cellular proliferation due to such diseases as cancer, autoimmune disorders and viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 5, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Kathleen Becherer, Nanibhushan Dattagupta, Yathi M. Naidu
  • Method for inhibiting cellular proliferation using antisense oligonucleotides to interleukin-6 receptor mRNA
    Patent number: 5716846
    Abstract: The present invention relates to methods of treating disease-associated cellular proliferation using oligonucleotides. In particular, it relates to the use of oligonulceotides which are substantially complementary to interleukin-6 receptor mRNA sequences. In the form of pharmaceutical compositions, these oligonucleotides are suitable for administration to human subjects for the treatment of abnormal cellular proliferation due to such diseases as cancer, autoimmune disorders and viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 10, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Steven Joel Brown, Nanibhushan Dattagupta, Yathi M. Naidu
  • Oligonucleotides specific for cytokine signal transducer gp130 mRNA
    Patent number: 5674995
    Abstract: The present invention relates to oligonucleotides which are effective inhibitors of disease-associated cellular proliferation. In particular, it relates to the use of oligonulceotides which are substantially complementary to gp130 mRNA sequences. In the form of pharmaceutical compositions, these oligonucleotides are suitable for administration to human subjects for the treatment of abnormal cellular proliferation due to such diseases as cancer, autoimmune disorders and viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 1997
    Assignee: Gen-Probe Incorporated
    Inventors: Kathleen Ann Becherer, Nanibhushan Dattagupta, Yathi M. Naidu